Novel Anticancer Triple Formula Based on Aptamer-Conjugated PEGylated Nanoliposomes
Background Cancer remains a leading cause of death worldwide, necessitating the development of affordable and innovative therapies to reduce its human and economic burden. Objectives In this study, we aimed to develop a synergistic anticancer formula encapsulated in nanoliposomes to enhance efficacy...
Saved in:
| Main Authors: | Ali Al-Samydai PhD, Hamdi Nsairat PhD, Moath Alqaraleh PhD, Maha N. Abu Hajleh PhD, Areej Jaber PhD, Lidia Al-Halaseh PhD, Hanan Azzam MS, Qasim Khalid Alazzawi PhD, Israa Al-Ani PhD, Simone Carradori PhD, Walhan Alshaer PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Technology in Cancer Research & Treatment |
| Online Access: | https://doi.org/10.1177/15330338251356548 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Total resection of superior vena cava in thymic atypical carcinoid without caval reconstructionCentral Message
by: Shuai Wang, PhD, et al.
Published: (2025-08-01) -
Macrophage Polarisation in the Tumour Microenvironment: Recent Research Advances and Therapeutic Potential of Different Macrophage Reprogramming
by: Rongqi Guo PhD, et al.
Published: (2025-01-01) -
Association of Circulating Inflammatory Biomarker Levels and Toxicity in Patients Undergoing Pelvic Radiation for Cancer: A Critical Review
by: Per Fessé, PhD, et al.
Published: (2025-06-01) -
Patient Opinions and Satisfaction Regarding Pharmacists Delivering Vaccinations in Community Pharmacies
by: Urszula Religioni PhD, et al.
Published: (2025-03-01) -
Ownership Matters: Not-for-Profit Chain Nursing Homes Have Higher Utilization of Agency Nursing Staff
by: Rohit Pradhan PhD, et al.
Published: (2024-10-01)